1. Home
  2. SMSI vs GLYC Comparison

SMSI vs GLYC Comparison

Compare SMSI & GLYC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SMSI
  • GLYC
  • Stock Information
  • Founded
  • SMSI 1982
  • GLYC 2003
  • Country
  • SMSI United States
  • GLYC United States
  • Employees
  • SMSI N/A
  • GLYC N/A
  • Industry
  • SMSI Computer Software: Prepackaged Software
  • GLYC Biotechnology: Pharmaceutical Preparations
  • Sector
  • SMSI Technology
  • GLYC Health Care
  • Exchange
  • SMSI Nasdaq
  • GLYC Nasdaq
  • Market Cap
  • SMSI 15.9M
  • GLYC 16.2M
  • IPO Year
  • SMSI 1995
  • GLYC 2014
  • Fundamental
  • Price
  • SMSI $0.81
  • GLYC $0.21
  • Analyst Decision
  • SMSI Strong Buy
  • GLYC Hold
  • Analyst Count
  • SMSI 1
  • GLYC 3
  • Target Price
  • SMSI $5.00
  • GLYC N/A
  • AVG Volume (30 Days)
  • SMSI 132.9K
  • GLYC 339.6K
  • Earning Date
  • SMSI 05-07-2025
  • GLYC 05-14-2025
  • Dividend Yield
  • SMSI N/A
  • GLYC N/A
  • EPS Growth
  • SMSI N/A
  • GLYC N/A
  • EPS
  • SMSI N/A
  • GLYC N/A
  • Revenue
  • SMSI $19,378,000.00
  • GLYC N/A
  • Revenue This Year
  • SMSI $31.76
  • GLYC N/A
  • Revenue Next Year
  • SMSI $44.43
  • GLYC N/A
  • P/E Ratio
  • SMSI N/A
  • GLYC N/A
  • Revenue Growth
  • SMSI N/A
  • GLYC N/A
  • 52 Week Low
  • SMSI $0.52
  • GLYC $0.14
  • 52 Week High
  • SMSI $2.57
  • GLYC $0.63
  • Technical
  • Relative Strength Index (RSI)
  • SMSI 42.90
  • GLYC 37.66
  • Support Level
  • SMSI $0.76
  • GLYC $0.23
  • Resistance Level
  • SMSI $0.86
  • GLYC $0.22
  • Average True Range (ATR)
  • SMSI 0.06
  • GLYC 0.02
  • MACD
  • SMSI -0.00
  • GLYC -0.00
  • Stochastic Oscillator
  • SMSI 34.06
  • GLYC 11.43

About SMSI Smith Micro Software Inc.

Smith Micro Software Inc is a provider of software solutions. It develops and markets wireless solutions for wireless service providers, mobile device and chipset manufacturers, and enterprise businesses. Its portfolio includes family safety software solutions to support families in the digital age and creating, sharing, and monetizing rich content, such as visual voice messaging, retail content display optimization and performance analytics on any product set. The company's only reportable segment is Wireless. Wireless segment includes the Family Safety (which includes SafePath), CommSuite, and ViewSpot families of products.

About GLYC GlycoMimetics Inc.

GlycoMimetics Inc is a clinical-stage biotechnology company. It is focused on the discovery and development of novel glycomimetic drugs to address unmet medical needs resulting from diseases in which carbohydrate biology plays a key role. Glycomimetics are molecules that mimic the structure of carbohydrates involved in important biological processes. Using expertise in carbohydrate chemistry and knowledge of carbohydrate biology, the company is developing a pipeline of proprietary glycomimetics that may inhibit disease-related functions of carbohydrates, such as the roles it play in inflammation, cancer, and infection.

Share on Social Networks: